The efficacy of acute electroconvulsive therapy in atypical depression.

Published

Journal Article

This study examined the characteristics and outcomes of patients with major depressive disorder (MDD), with or without atypical features, who were treated with acute bilateral electroconvulsive therapy (ECT).Analyses were conducted with 489 patients who met DSM-IV criteria for MDD. Subjects were identified as typical or atypical on the basis of the Structured Clinical Interview for DSM-IV obtained at baseline prior to ECT. Depression symptom severity was measured by the 24-item Hamilton Rating Scale for Depression (HAM-D(24)) and the 30-item Inventory of Depressive Symptomatology-Self-Report (IDS-SR(30)). Remission was defined as at least a 60% decrease from baseline in HAM-D(24) score and a total score of 10 or below on the last 2 consecutive HAM-D(24) ratings. The randomized controlled trial was performed from 1997 to 2004.The typical (N = 453) and atypical (N = 36) groups differed in several sociodemographic and clinical variables including gender (p = .0071), age (p = .0005), treatment resistance (p = .0014), and age at first illness onset (p < .0001) and onset of current episode (p = .0008). Following an acute course of bilateral ECT, a considerable portion of both the typical (67.1%) and the atypical (80.6%) groups reached remission. The atypical group was 2.6 (95% CI = 1.1 to 6.2) times more likely to remit than the typical group after adjustment for age, psychosis, gender, clinical site, and depression severity based on the HAM-D(24).Acute ECT is an efficacious treatment for depressed patients with typical or atypical symptom features.clinicaltrials.gov Identifier: NCT00000375.

Full Text

Duke Authors

Cited Authors

  • Husain, MM; McClintock, SM; Rush, AJ; Knapp, RG; Fink, M; Rummans, TA; Rasmussen, K; Claassen, C; Petrides, G; Biggs, MM; Mueller, M; Sampson, S; Bailine, SH; Lisanby, SH; Kellner, CH

Published Date

  • March 2008

Published In

Volume / Issue

  • 69 / 3

Start / End Page

  • 406 - 411

PubMed ID

  • 18278988

Pubmed Central ID

  • 18278988

Electronic International Standard Serial Number (EISSN)

  • 1555-2101

International Standard Serial Number (ISSN)

  • 0160-6689

Language

  • eng